特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
926840

新型コロナウイルス感染症 (COVID-19) が経済へ及ぼす影響、およびGDP・観光/旅行・医療市場の予測:2020年~2025年

Covid-19 Economic Impact and Market Forecasts for Gross Domestic Product, Tourism/travel, and Medical by Country using 3 scenarios. Includes customization with Executive and Consultant Guides. 2020-2025

出版日: | 発行: Howe Sound Research | ページ情報: 英文 341 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.60円
新型コロナウイルス感染症 (COVID-19) が経済へ及ぼす影響、およびGDP・観光/旅行・医療市場の予測:2020年~2025年
出版日: 2020年03月01日
発行: Howe Sound Research
ページ情報: 英文 341 Pages
納期: 即日から翌営業日
担当者のコメント
Howe Sound Research (ハウサウンドリサーチ)は、カナダのバンクーバーを拠点にバイオテクノロジー、計装、医薬品および臨床診断市場についての調査を展開する市場調査会社です。3月頭時点において考えうる新型コロナウィルスが経済社会に与えるであろうインパクトの各シナリオを考察する最新レポートです。過去の感染症パンデミックの歴史やCOVID 19ワクチンの開発候補およびその企業のリスト、また治療、診断、PPE(マスクや防護服などの個人用保護具)セグメントごとのキープレーヤープロフなども掲載します。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

新型コロナウイルス感染症 (COVID-19) はパンデミックへと変化しつつあります。リスクと可能性を把握することで、組織は変化に備えることが可能となり、産業および国が受ける影響について推計できます。

当レポートでは、新型コロナウイルス感染症 (COVID-19) が経済、GDP (国内総生産)、 観光/旅行市場、および医療市場へ及ぼす影響について調査し、ウイルスの概要、コロナウイルスの概要、診断と治療、3つのシナリオを用いた予測、最新の開発動向、および主要企業のプロファイルなどを提供しています。

第1章 イントロダクションと市場の定義

第2章 パンデミックの概要

  • ウイルスとは何か?
    • ウイルスは生きているか?
    • ウイルスの構造
    • ウイルスのゲノム
    • ウイルスの変異
  • コロナウイルス
    • 重症急性呼吸器症候群 (SARS)
    • 中東呼吸器症候群 (MERS)
    • 新型コロナウイルス感染症 (COVID-19)
  • パンデミックの診断
    • リスク管理
    • 診断技術:ゲノム・WGSの役割
    • 診断技術:免疫測定法
    • 診断技術:その他
    • 上市までの時間・準備の問題
  • 治療
    • ワクチン
    • ワクチンの二つの役割
    • 抗ウイルス剤

第3章 COVID-19のシナリオ

  • シナリオの概要
  • シナリオ1.まん延の抑制 & 早期のワクチン
  • シナリオ2.まん延の持続 & 中期のワクチン
  • シナリオ3.非局地的なまん延 & 後期のワクチン

第4章 最新の開発動向

  • 最新の開発動向:重要性および本章の使用法

第5章 主要企業のプロファイル

  • 主要企業:治療
    • Applied DNA Sciences, Inc
    • Codagenix
    • GeoVax Labs, Inc.
    • Takis Biotech
    • Evvivax.
    • Zydus Cadila
    • MIGAL Galilee Research Institute
    • Generex Biotechnology Corporation
    • Moderna Therapeutics.
    • Novavax
    • Bravovax
    • Ascletis Pharma
    • Janssen Pharmaceuticals
    • Altimmune.
    • Greffex Inc.
    • CanSino Biologics, Inc.
    • ExpreS2ion Biotechnologies ApS
    • Clover Biopharmaceuticals.
    • Vaxil Bio Ltd.
    • iBio Pharma Inc.
    • Tonix Pharmaceuticals
    • Curevac
    • ImmunoPrecise
    • X4 Pharmaceuticals
    • Inovio Pharmaceuticals
    • Innovation Pharmaceuticals
    • CytoDyn
    • BIOXYTRAN
    • BioCryst Pharmaceuticals
    • Vir Biotechnology
    • NanoViricides
    • TAKISAWA Technology Co., Ltd.
    • Westway Health
    • Nabriva Therapeutics.
    • Nemesis Bioscience
    • Armata Pharmaceuticals, Inc.
    • Lumavita
    • Priaxon.
    • Union Therapeutics.
    • Enanta Pharmaceuticals, Inc.
    • Demuris
    • Prommune.
    • Vaxart
    • Alexion Pharmaceuticals
    • SelectX Pharmaceuticals, Inc
    • TaiGen Biotechnology Co., Ltd.
    • Abbvie.
    • KYORIN Pharmaceutical Co., Ltd
    • Forge Therapeutics.
    • Alopexx Vaccine LLC.
    • Integrated Biotherapeutics
    • Hennepin Life Sciences
    • Contrafect Corporation.
    • Basilea Pharmaceutica Ltd.
    • AiCuris
    • Redx Pharma Plc/ Redx Anti Infectives Ltd.
    • Centauri Therapeutics Ltd
    • Combioxin SA
    • Mutabilis SAS
    • Vaxdyn
    • Vibiosphen
    • Bioaster
    • Vivexia
    • KBP Biosciences
    • Merck.
    • Symphogen.
    • Johnson & Johnson (Janssen)
    • Pfizer
    • Allergan.
    • GlaxoSmithKline
    • Novartis
    • Gilead Sciences
    • AstraZeneca
    • Sanofi.
    • Shionogi Inc.
    • Cipla
    • DSM Sinochem Pharmaceuticals
    • Wockhardt Ltd.
    • VenatoRx Pharmaceuticals.
  • 主要企業:診断
    • Abbott Diagnostics.
    • Accelerate Diagnostics
    • Ador Diagnostics
    • Akkoni Biosystems
    • Alveo Technologies
    • Applied BioCode
    • Aus Diagnostics.
    • BD Diagnostics
    • Biocartis
    • BioFire Diagnostics
    • bioMerieux
    • Bio-Rad Laboratories
    • Bosch Healthcare Solutions GmbH
    • Cepheid
    • Co-Diagnostics
    • Cue Health
    • Curetis
    • Diagenode Diagnostics
    • Diascopic
    • Diasorin
    • Expedeon
    • Fusion Genomics.
    • GenePOC Diagnostics.
    • GenMark Dx
    • Hologic
    • Immunexpress
    • Inflammatix
    • Invetech
    • Janssen Diagnostics
    • Karius
    • Lexigene
    • Luminex
    • Mbio Diagnostics
    • Meridian Bioscience.
    • Mesa Biotech
    • Mobidiag.
    • Nanomix
    • Oxford Nanopore
    • Panagene
    • Primerdesign
    • Prominex
    • Qiagen (Statdx)
    • Quantumdx.
    • Quidel
    • Roche Molecular Diagnostics
    • Saw Diagnostics
    • Seegene
    • Sensovation.
    • Siemens Healthineers (Fast Track Diagnostics).
    • SkylineDx
    • Sona Nanotech
    • T2 Biosystems.
    • Thermo Fisher
    • Veradus Labs
    • Veramarx

第6章 COVID-19がGDPへ及ぼす経済的な影響

  • 経済的な影響の概要:国別
  • 世界の観光市場:セグメント別 - 概要
  • 世界の医療市場:セグメント別 - 概要

第7章 世界の観光市場:セグメント・シナリオ別

  • ホテル
  • 陸上輸送
  • 航空
  • クルージング市場
  • その他の観光

第8章 世界の医療市場:セグメント・シナリオ別

  • 治療
  • 診断
  • PPE
図表

Table of Tables

  • Table 1: Who List of Potential Pandemic Pathogens
  • Table 2: Characteristics of Coronavirus Pandemic Infections
  • Table 3: List of 31 COVID 19 Vaccine Candidates and Companies
  • Table 4: The Three Scenarios
  • Table 5: Scenario 1 Assumptions
  • Table 6: Scenario 1 Country Impact Analysis Table
  • Table 7: Scenario 2 Assumptions
  • Table 8: Scenario 2 Country Impact Analysis Table
  • Table 9: Scenario 3 Assumptions
  • Table 10: Scenario 3 Country Impact Analysis Table
  • Table 11: - Economic Impact by Country Scenario 1
  • Table 12: - Economic Impact by Country Scenario 2
  • Table 13: - Economic Impact by Country Scenario 3
  • Table 14: Tourism Global Market by Segment and Scenario
  • Table 15: Medical Global Market by Segment and Scenario
  • Table 16: Hotel Market by Scenario and by Country
  • Table 17: Ground Market by Scenario and by Country
  • Table 18: Air Travel by Scenario and by Country
  • Table 19: HIV Cruise Market by Scenario and by Country
  • Table 20: Other Tourism by Scenario andby Country
  • Table 21: Therapeutic Markets by Scenario and by Country
  • Table 22: Diagnostics Market Growth by Scenario and by Country
  • Table 23: PPE Market by Scenario and by Country

Table of Figures

  • Figure 1: Global Distribution Pandemic Preparedness
  • Figure 2: Global Pandemic Pathogen Status
  • Figure 3: Estimated Economic Impact of Viral Pandemic by Region
  • Figure 4: Historical Pandemics Infographic
  • Figure 5: Antigenic Drift Creates a new Strain of Virus
  • Figure 6: Structure of Coronaviruses
  • Figure 7: 2019 Economic Impact Chart Scenario 1
  • Figure 8: 2019 Economic Impact Chart Scenario 2
  • Figure 9: 2019 Economic Impact Chart Scenario 3
  • Figure 10: Tourism Global Market by Segment and Scenario - 2019 vs. 2024
  • Figure 11: Tourism Global Market by Segment and Scenario 2019
  • Figure 12: Tourism Global Market by Segment 2024
  • Figure 13: Tourism Global Market by Segment Share by Year
  • Figure 14: Medical Global Market by Segment and Scenario - 2019 vs. 2024
  • Figure 15: Medical Global Market by Segment and Scenario 2019
  • Figure 16: Medical Global Market by Segment and Scenario 2024
  • Figure 17: Hotel Market Growth by Scenario
  • Figure 18: Ground Market Growth by Scenario
  • Figure 19: Air Travel Growth by Scenario
  • Figure 20: Cruise Market Growth by Scenario
  • Figure 21: Other Tourism Growth by Scenario
  • Figure 22: Therapeutic Market Growth by Scenario
  • Figure 23: Diagnostics Market Growth by Scenario
  • Figure 24: PPE Market Growth by Scenario
目次

OVERVIEW:

COVID-19 is turning into a pandemic. Prepare your organization for the changes beginning to take place. Understand the risks and probabilities. Understand how your industry and your nation will be affected. This in-depth report puts you in control of the numbers you need to prepare. Some countries and some industries will be more affected than others. Some may not be affected at all.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

  • i. COVID-19. Strategic Situation Analysis
  • ii. COVID-19. Guidance for Executives
  • iii. COVID-19. Guidance for Management Consultants and Investment Advisors

1. Introduction and Market Definition

  • 1.1. What are Pandemics?
  • 1.2. The Role of Zoonosis
  • 1.3. Market Definition
    • 1.3.1. Revenue Market Size
    • 1.3.2. Gross Domestic Product
    • 1.3.3. Tourism - Hotels
    • 1.3.4. Tourism - Ground
    • 1.3.5. Tourism - Air
    • 1.3.6. Tourism - Cruise
    • 1.3.7. Tourism - Other
    • 1.3.8. Medical - Therapeutic
    • 1.3.9. Medical - Diagnostic
    • 1.3.10. Medical - PPE
  • 1.4. Methodology
    • 1.4.1. Authors
    • 1.4.2. Sources
  • 1.5. Historical Perspective on Pandemics
    • 1.5.1. HIV/AIDS PANDEMIC 2005-2012
    • 1.5.2. FLU PANDEMIC 1968
    • 1.5.3. ASIAN FLU 1956-1958
    • 1.5.4. SPANISH FLU 1918
    • 1.5.5. SIXTH CHOLERA PANDEMIC 1910-1911
    • 1.5.6. FLU PANDEMIC 1889-1890
    • 1.5.7. THE BLACK DEATH 1346-1353

2. The Pandemic Overview

  • 2.1. What is a Virus?
    • 2.1.1. Is a Virus Alive?
    • 2.1.2. Viral Structure
    • 2.1.3. The Viral Genome
    • 2.1.4. Viral Mutation
  • 2.2. The Coronavirus
    • 2.2.1. Severe acute respiratory syndrome (SARS)
    • 2.2.2. Middle East respiratory syndrome (MERS)
    • 2.2.3. Coronavirus disease 2019 (COVID-19)
      • 2.2.3.1. Signs and symptoms
      • 2.2.3.2. Cause
      • 2.2.3.3. Diagnosis
      • 2.2.3.4. Prevention
      • 2.2.3.5. Management
      • 2.2.3.6. Prognosis
      • 2.2.3.7. Epidemiology
      • 2.2.3.10. Misinformation about the outbreak
  • 2.3. Pandemic Diagnostics
    • 2.3.1. Risk Management - Spark and Spread
    • 2.3.2. Dx Technology - Genomic and WGS Role
    • 2.3.3. Dx Technology - Immunoassay
    • 2.3.4. Dx Technology - Other
    • 2.3.5. Time to Market and Preparedness Issues
  • 2.4. Therapeutics
    • 2.4.1. Vaccine
    • 2.4.2. Dual Role of Vaccines
    • 2.4.2. Antiviral

3. COVID-19. Scenarios

  • 3.1. Scenarios Overview
  • 3.2. Scenario 1. Limited Spread & Early Vaccine
  • 3.3. Scenario 2. Contained Spread & Midterm Vaccine
  • 3.4. Scenario 3. Uncontained Spread & Late Vaccine

4. Recent Developments

  • 4.1. Recent Developments - Importance and How to Use This Section
    • 4.1.1. Importance of These Developments
    • 4.1.2. How to Use This Section
      • Generex Signs Contract to Develop a COVID-19 Vaccine
      • Applied DNA, Takis Biotech Partner To Design COVID-19 Vaccines
      • Codagenix Developing a Coronavirus Vaccine
      • Breakthrough From MIGAL Research Institute in Development of COVID-19 Vaccine
      • Novavax Advances Development of Novel COVID-19 Vaccine
      • COVID-19 Causes Air Travel to Fall for first time in 11 Years
      • Steep Drop In Chinese Air Travel Demand
      • New Tech Could Make Coronavirus Vaccine in Record Time
      • Vaxart Announces Initiation of Coronavirus Vaccine Program
      • Coronavirus Detection Test Development by Co-Diagnostics
      • GeoVax, BravoVax to develop vaccine for coronavirus
      • Diagnosing coronavirus in the lab
      • Veredus Lab develops test for coronavirus detection
      • U.S. Pork Producers fear Pandemic
      • First New HIV Strain in 19 Years Identified
      • Flu-Like Epidemic Could Kill 80 Mn Globally
      • Nipah Virus a Global Threat
      • New DRC Ebola cases confirmed as FDA OKs rapid test
      • Ontera Awarded Contract for Zika Genotyping Test
      • Two New Members Join Global Diagnostics Network
      • BARDA Funding Health Security Solutions

5. Profiles of Key Players

  • 5.1. Key Players - Therapeutics
    • Applied DNA Sciences, Inc
    • Codagenix
    • GeoVax Labs, Inc.
    • Takis Biotech
    • Evvivax
    • Zydus Cadila
    • MIGAL Galilee Research Institute
    • Generex Biotechnology Corporation
    • Moderna Therapeutics
    • Novavax
    • Bravovax
    • Ascletis Pharma
    • Janssen Pharmaceuticals
    • Altimmune
    • Greffex Inc.
    • CanSino Biologics, Inc.
    • ExpreS2ion Biotechnologies ApS
    • Clover Biopharmaceuticals
    • Vaxil Bio Ltd.
    • iBio Pharma Inc
    • Tonix Pharmaceuticals
    • Curevac
    • ImmunoPrecise
    • X4 Pharmaceuticals
    • Inovio Pharmaceuticals
    • Innovation Pharmaceuticals
    • CytoDyn
    • BIOXYTRAN
    • BioCryst Pharmaceuticals
    • Vir Biotechnology
    • NanoViricides
    • TAKISAWA Technology Co., Ltd
    • Westway Health
    • Nabriva Therapeutics
    • Nemesis Bioscience
    • Armata Pharmaceuticals, Inc.
    • Lumavita
    • Priaxon
    • Union Therapeutics
    • Enanta Pharmaceuticals, Inc.
    • Demuris
    • Prommune
    • Vaxart
    • Alexion Pharmaceuticals
    • SelectX Pharmaceuticals, Inc
    • TaiGen Biotechnology Co., Ltd.
    • Abbvie
    • KYORIN Pharmaceutical Co., Ltd
    • Forge Therapeutics
    • Alopexx Vaccine LLC
    • Integrated Biotherapeutics
    • Hennepin Life Sciences
    • Contrafect Corporation
    • Basilea Pharmaceutica Ltd.
    • AiCuris
    • Redx Pharma Plc/ Redx Anti Infectives Ltd.
    • Centauri Therapeutics Ltd
    • Combioxin SA
    • Mutabilis SAS
    • Vaxdyn
    • Vibiosphen
    • Bioaster
    • Vivexia
    • KBP Biosciences
    • Merck
    • Symphogen
    • Johnson & Johnson (Janssen)
    • Pfizer
    • Allergan
    • GlaxoSmithKline
    • Novartis
    • Gilead Sciences
    • AstraZeneca
    • Sanofi
    • Shionogi Inc
    • Cipla
    • DSM Sinochem Pharmaceuticals
    • Wockhardt Ltd.
    • VenatoRx Pharmaceuticals
  • 5.2. Key Players - Diagnostics
    • Abbott Diagnostics
    • Accelerate Diagnostics
    • Ador Diagnostics
    • Akkoni Biosystems
    • Alveo Technologies
    • Applied BioCode
    • Aus Diagnostics
    • BD Diagnostics
    • Biocartis
    • BioFire Diagnostics
    • bioMérieux
    • Bio-Rad Laboratories
    • Bosch Healthcare Solutions GmbH
    • Cepheid
    • Co-Diagnostics
    • Cue Health
    • Curetis
    • Diagenode Diagnostics
    • Diascopic
    • Diasorin
    • Expedeon
    • Fusion Genomics.
    • GenePOC Diagnostics
    • GenMark Dx
    • Hologic
    • Immunexpress
    • Inflammatix
    • Invetech
    • Janssen Diagnostics
    • Karius
    • Lexigene
    • Luminex
    • Mbio Diagnostics
    • Meridian Bioscience
    • Mesa Biotech
    • Mobidiag
    • Nanomix
    • Oxford Nanopore
    • Panagene
    • Primerdesign
    • Prominex
    • Qiagen (Statdx)
    • Quantumdx
    • Quidel
    • Roche Molecular Diagnostics
    • Saw Diagnostics
    • Seegene
    • Sensovation
    • Siemens Healthineers (Fast Track Diagnostics)
    • SkylineDx
    • Sona Nanotech
    • T2 Biosystems
    • Thermo Fisher
    • Veradus Labs
    • Veramarx

6. COVID-19. Economic Impact on Gross Domestic Product

  • 6.1. Economic Impact Overview by Country
    • 6.1.1. Table - Economic Impact by Country Scenario 1
    • 6.1.2. Chart - Economic Impact by Country Scenario 1
    • 6.1.3. Table - Economic Impact by Country Scenario 2
    • 6.1.4. Chart - Economic Impact by Country Scenario 2
    • 6.1.5. Table - Economic Impact by Country Scenario 3
    • 6.1.6. Chart - Economic Impact by Country Scenario 3
  • 6.2. Tourism Global Market by Segment - Overview
    • 6.2.1. Table - Tourism Global Market by Segment and Scenario
    • 6.2.2. Chart - Tourism Global Market by Segment and Scenario - 2019/2024 Comparison
    • 6.2.3. Chart - Tourism Global Market by Segment and Scenario - 2019
    • 6.2.4. Chart - Tourism Global Market by Segment and Scenario -2024
    • 6.2.5. Chart - Tourism Global Market by Segment and Scenario - Share by Year
  • 6.3. Medical Global Market by Segment and Scenario - Overview
    • 6.3.1. Table - Medical Global Market by Segment and Scenario
    • 6.3.2. Chart - Medical Global Market by Segment and Scenario - 2019/2024 Comparison
    • 6.3.3. Chart - Medical Global Market by Segment and Scenario - 2019
    • 6.3.4. Chart - Medical Global Market by Segment and Scenario -2024
    • 6.3.5. Chart - Medical Global Market by Segment and Scenario - Share by Year

7. Tourism Global Markets - By Segment and Scenario

  • 7.1. Hotels
    • 7.1.1. Table Hotel Market by Scenario and by Country
    • 7.1.2. Chart - Hotel Market Growth by Scenario
  • 7.2. Ground
    • 7.2.1. Table Ground Market by Scenario and by Country
    • 7.2.2. Chart - Ground Market Growth by Scenario
  • 7.3. Air Travel
    • 7.3.1. Table Air Travel by Scenario and by Country
    • 7.3.2. Chart - Air Travel Growth by Scenario
  • 7.4. Cruise Market
    • 7.4.1. Table Cruise Market by Scenario and by Country
    • 7.4.2. Chart - Cruise Market Growth by Scenario
  • 7.5. Other Tourism
    • 7.5.1. Table Other Tourism by Scenario andby Country
    • 7.5.2. Chart - Other Tourism Growth by Scenario

8. Medical Global Markets - By Segment and Scenario

  • 8.1. Therapeutic
    • 8.1.1. Table Therapeutic Markets by Scenario and by Country
    • 8.1.2. Chart - Therapeutic Markets Growth by Scenario
  • 8.2. Diagnostics
    • 8.2.1. Table Diagnostics Market Growth by Scenario and by Country
    • 8.2.2. Chart - Diagnostics Market Growth by Scenario
  • 8.3. PPE
    • 8.3.1. Table PPE Market by Scenario and by Country
    • 8.3.2. Chart - PPE Market Growth by Scenario
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.